Cargando…
Low-Risk Essential Thrombocythemia: A Comprehensive Review
Essential thrombocythemia (ET) is a chronic myeloproliferative neoplasm characterized by a persistently elevated platelet count in the absence of a secondary cause. The clinical consequences of uncontrolled thrombocytosis can include both thrombosis and hemorrhage. Patients with features conferring...
Autores principales: | Robinson, Andrew J., Godfrey, Anna L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051994/ https://www.ncbi.nlm.nih.gov/pubmed/33880431 http://dx.doi.org/10.1097/HS9.0000000000000521 |
Ejemplares similares
-
Correction Notice: Low-risk Essential Thrombocythemia: A Comprehensive Review
Publicado: (2022) -
Essential thrombocythemia
por: Brière, Jean B
Publicado: (2007) -
Essential Thrombocythemia in Children and Adolescents
por: Putti, Maria Caterina, et al.
Publicado: (2021) -
Emerging treatments for essential thrombocythemia
por: Okoli, Steven, et al.
Publicado: (2011) -
Ruxolitinib for the Treatment of Essential Thrombocythemia
por: Gunawan, Arief, et al.
Publicado: (2018)